Sun Pharmaceutical Industries LtdSUNPHARMA:NSI

18.40 / 1.89%
Latest price in INRToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of May 28 2015 10:40 BST.


As of last trade Sun Pharmaceutical Industries Ltd (SUNPHARMA:NSI) traded at 957.15, 20.29 % below its 52-week high of 1,200.8, set on Apr 07, 2015.

52-week range
May 29 2014
Apr 07 2015
Day high978.75
Day low947.50
Previous close975.55
Average volume2.85m
Shares outstanding2.41bn
Free float1.05bn
P/E (TTM)34.08
Market cap2.35tn INR
EPS (TTM)28.63 INR
Annual div (IAD)1.50 INR
Annual div yield (IAD)0.15%
Div ex-dateSep 11 2014
Div pay-dateSep 30 2014
Data delayed at least 15 minutes, as of May 28 2015 10:40 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Sun Pharmaceutical Industries Ltd-2.23 %+3.82 %+13.62 %+64.18 %+487.21 %
CNX NIFTY IDX-1.10 %+0.51 %-1.95 %+13.62 %+64.38 %
IN/HEALTH CARE-1.18 %+4.64 %+9.59 %+39.14 %+66.40 %
IN/PHARMACEUTICALS-0.95 %+4.68 %+10.02 %+40.37 %+67.79 %
Data delayed at least 15 minutes, as of May 28 2015 10:40 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.